Lytic Bacteriophage Screening Strategies for Multidrug-Resistant Bloodstream Infections in a Burn Intensive Care Unit

Med Sci Monit. 2019 Nov 6:25:8352-8362. doi: 10.12659/MSM.917706.

Abstract

BACKGROUND Increasing antibiotic resistance and multidrug resistance (MDR) in patients with bloodstream infection (BSI) has resulted in treatment using bacteriophage. This study aimed to identify Gram-negative bacilli and Gram-positive cocci and antibiotic resistance in patients with BSI in a burn intensive care unit (BICU). The environment, including sewage systems, were investigated for the presence of lytic bacteriophage. MATERIAL AND METHODS Between January 2011 to December 2017, 486 patients with BSI were admitted to the BICU. Blood culture identified the main infectious organisms. Bacterial screening tests for antibiotic resistance included the D test and the modified Hodge test (MHT). Lytic bacteriophage was isolated from the environment. RESULTS In 486 patients with BSI, the main causative organisms were Gram-negative bacilli (64.6%), Gram-positive cocci (27.7%), and fungi (7.7%). The main pathogenic organisms that showed multidrug resistance (MDR) were Acinetobacter baumannii (26.0%), Staphylococcus aureus (16.8%), and Pseudomonas aeruginosa (14.2%). Bacteriophage was mainly isolated from Gram-negative bacilli. Screening of hospital and residential sewage systems identified increased levels of bacteriophage in hospital sewage. CONCLUSIONS The causative organisms of BSI and the presence of MDR in a hospital BICU were not typical, which supports the need for routine bacterial monitoring. Hospital sewage provides a potential source of bacteriophage for the treatment of MDR pathogenic bacteria.

MeSH terms

  • Acinetobacter baumannii / drug effects
  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Bacteremia / drug therapy
  • Bacterial Infections / diagnosis*
  • Bacterial Infections / drug therapy
  • Bacterial Infections / etiology*
  • Bacteriophages
  • Burn Units
  • China
  • Communicable Diseases
  • Cross Infection / drug therapy
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Female
  • Humans
  • Intensive Care Units
  • Male
  • Mass Screening / methods
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pseudomonas / drug effects
  • Pseudomonas Infections / drug therapy
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents